Moxonidine

Moxonidine

Moxonidine is a selective agonist at the imidazoline receptor subtype 1 (I1). This receptor subtype is found in both the rostral ventro-lateral pressor and ventromedial depressor areas of the medulla oblongata. Moxonidine therefore causes a decrease in sympathetic nervous system activity and, therefore, a decrease in blood pressure.

Indications: 

Hypertension, mild iron deficiency anaemias etc.

Side effects: 

Dry mouth, headache, nausea, insomnia, dizziness, tiredness etc.

Dosage forms:
Moxonidine 0.2 mg tablets
Moxonidine 0.3 mg tablets

Compositions:

Brand names:

Moxcent (Unichem)

Moxilong (Micro Carsyon)

Moxovas (Macleods)

Ajay Kamboj

Ajay Kamboj is an entrepreneur and business owners associated with many Ayurvedic and Pharmaceutical start-ups. With years of experience in Ayurvedic product marketing, pharmaceutical distribution, franchise development, and client relationship management, he regularly shares practical business insights based on real-world experiences. His articles focus on business growth, entrepreneurship, customer management, and lessons learned from the healthcare and wellness industry.

Leave a Reply Cancel reply

Exit mobile version